|
Biochemical markers | Samples | Enzyme activities and levels | References |
|
Superoxide dismutase (SOD) | Tissue BC tissue () vs. normal bladder tissue () | SOD positive (%) 49.3% vs. 80% () | [35] |
BC tissue () vs. normal bladder tissue () | SOD activity (IU/mg) vs. () | [36] |
BC tissues () vs. normal bladder tissue () | SOD activity (U/mg) 40 vs. 80 | [37] |
BC tissue () vs. normal bladder tissue () | SOD activity (U/mg prot) vs. () | [38] |
Serum BC patients () vs. controls () | SOD activity (U/mL) vs. () | [39] |
BC patients () vs. controls () | vs. () | [40] |
|
Catalase (CAT) | Tissue BC tissue () vs. normal bladder tissue () | CAT positive (%) 44% vs. 73.3 % () | [35] |
BC tissue () vs. normal bladder tissue () | CAT activity (IU/mg) vs. () | [36] |
BC tissue () vs. normal bladder tissue () | CAT activity (IU/mg) vs. () | [38] |
Serum BC patients () vs. controls () | CAT activity (u/L) vs. () | [39] |
|
Glutathione peroxide (GTPx) | Tissue BC tissue () vs. normal bladder tissue () | GTPx positive (%) 45.3% vs. 63.3 % () | [35] |
BC tissue () vs. normal bladder tissue () | GTPx activity (IU/mg) vs. () | [36] |
BC tissue () vs. normal bladder tissue () | GTPx activity (U/g) 35 vs. 85 | [37] |
Serum BC patients () vs. controls () | GTPx activity (U/L) vs. () | [39] |
BC patients () vs. controls () | vs. () | [40] |
Erythrocyte Grade III BC patients () vs. controls () | GTPx activity (U/g Hb) 4 vs. 5 () | [43] |
|
Glutathione (GSH) | Tissue BC tissue () vs. normal bladder tissue () | GSH levels (μM/mg) vs. () | [42] |
BC tissues () vs. normal bladder tissue () | GSH levels (mg/mL) 35 vs. 75 | [37] |
|
Paraoxonase-1 (PON1) | Serum BC patients () vs. controls () | PON1 paraoxonase activity (U/L) vs. () PON1 arylesterase activity (U/L) vs. () | [47] |
BC patients () vs. controls () | PON1 paraoxonase activity (U/L) 239.1 (116.6–457.4) vs. 253.1 (149.5–434.7) | [48] |
BC patients () vs. controls () | PON1 concentration (mg/L) 70.6 (18.2–185.2) vs. 101.6 (52.9–325.1) |
|
Paraoxonase-2 (PON2) | Tissue BC tissues () vs. normal bladder tissue () | PON2 expression levels: 2.01-fold higher in BC tissue vs. normal tissue () | [49] |
BC tissues vs. normal bladder tissue | PON2 expression levels: 4.01-fold higher BC tissue vs. normal tissue () | [44] |
|